What is it? Why is it important?

Study Registries are web-based platforms where detailed information about studies is published.

Like clinicaltrials.gov a registry has the aim to:

  • Provide patients, their families, health care professionals, researchers, and the public with easy access to information on publicly and privately supported clinical studies


Sharing scientific information is an important mean to further clinical research with the goal to provide improved treatment options to the general population.

What do I need to do?

During set-up phase and upon EC and RA approval the study was registered in:

  • An international public WHO registry, and
  • The federal database KOFAM (SNCTP)

Upon study completion, discontinuation or interruption, applicable updates must be made in these registries.

Registries have clear requirements regarding type of information that must be published and made available to the public (e.g. included participants, study design and methods used, results including their interpretation).

Where can I get help?

Your local CTU can support you with experienced staff regarding this topic

External Links

Swissethics - see in particular

  • BASEC: EC submission protal
  • RAPS: EC approved projects in Switzerland

For study registration access: 


HRA – see in particular article

  • Art. 56 Registration

ClinO - see in particular articles

  • Art. 64 - 67 Registration
  • BASEC – Business Administration System for Ethics Committees
  • ClinO – Clinical Trials Ordinance
  • CTU – Clinical Trials Unit
  • EC – Ethics Committee
  • EC/RA – Ethics Committee / Regulatory Author
  • HRA – Human Research Act
  • KOFAM – Coordination Portal for Human Research
  • RAPS – Registry of all Projects in Switzerland
  • SNCTP – Swiss National Clinical Trials Portal
  • SP-INV – Sponsor-Investigator
  • WHO – World Health Organization
Completion ↦ Management ↦ Publishing ↦ Study Registries

Provides some background knowledge and basic definitions

Basic Protocol
Basic Statistics
Basic Monitoring
Basic Drug or Device
Basic Biobanking

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Protocol
Concept Statistics
Concept Drug or Device
Concept Biobanking

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Protocol
Development Statistics
Development Drug or Device
Development Biobanking

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Protocol
Set-Up Ethics and Laws
Set-Up Statistics
Set-Up Quality and Risk
Set-Up Drug or Device
Set-Up Biobanking

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Protocol
Conduct Statistics
Conduct Drug or Device
Conduct Biobanking

Starts with last study visit completed

Ends after study publication and archiving

Completion Protocol
Completion Statistics
Completion Drug or Device
Completion Biobanking
Current Path (click to copy): Completion ↦ Management ↦ Publishing ↦ Study Registries

Please note: the Easy-GCS tool is currently under construction.